{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:44Z","timestamp":1790456084463,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31371168"],"award-info":[{"award-number":["31371168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872791"],"award-info":[{"award-number":["31872791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00455","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T06:47:00Z","timestamp":1562914020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Effects of Lifestyle Modification and Anti-diabetic Medicine on Prediabetes Progress: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Zhi","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus\u2013present and future perspectives","volume":"8","author":"Chen","year":"2011","journal-title":"Nat Rev Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988-2012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA."},{"key":"B3","unstructured":"Intermediate States of Hyperglycemia238779781999"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance","volume":"55","author":"Nathan","year":"2007","journal-title":"Diabetes Care."},{"key":"B7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1742-1241.2008.01705.x","article-title":"Prediabetes: a must to recognise disease state","volume":"62","author":"Shehab","year":"2010","journal-title":"Int J Clin Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/cd16-0067","article-title":"Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers","volume":"35","year":"2017","journal-title":"Clin Diabetes."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","article-title":"Long-term Sustainability of Diabetes Prevention Approaches: a systematic review and meta-analysis of randomized clinical trials","volume":"177","author":"Haw","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1462-8902.2004.0348.x","article-title":"Thiazolidinedione therapy in the prevention\/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance","volume":"6","author":"Durbin","year":"2004","journal-title":"Diabetes Obesity Metabol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00423146","article-title":"Worsening to diabetes in men with impaired glucose tolerance (borderline diabetes)","volume":"16","author":"Jarrett","year":"1979","journal-title":"Diabetologia."},{"key":"B15","first-page":"44","article-title":"Programme grants for applied research","volume-title":"A Community-Based Primary Prevention Programme for Type 2 Diabetes Mellitus Integrating Identification and Lifestyle Intervention for Prevention: A Cluster Randomised Controlled Trial.","author":"Davies","year":"2017"},{"key":"B16","author":"Stewart","year":"2011","journal-title":"Cochrane Handbook for Systematic Reviews of Intervention."},{"key":"B17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(10)60746-5","article-title":"Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study","volume":"376","author":"Zinman","year":"2010","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance","volume":"20","author":"Pan","year":"1997","journal-title":"Da Qing IGT Diabetes Study Diabetes Care."},{"key":"B19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","author":"Bosch","year":"2006","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2458-9-342","article-title":"Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK","volume":"9","author":"Penn","year":"2009","journal-title":"BMC Public Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2796.2006.01633.x","article-title":"Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance","volume":"259","author":"Eriksson","year":"2006","journal-title":"J Inter Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1001\/archinte.160.9.1321","article-title":"Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults","volume":"160","author":"Heymsfield","year":"2000","journal-title":"Arch Inter Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/dc09-1150","article-title":"Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)","volume":"33","author":"Ramachandran","year":"2010","journal-title":"Diabetes Care."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1210\/jc.2015-4013","article-title":"Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes","volume":"101","author":"Jorde","year":"2016","journal-title":"J Clin Endocrinol Metabol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"J Vasc Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance","volume":"373","author":"Kawamori","year":"2009","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males","volume":"67","author":"Kosaka","year":"2005","journal-title":"Diabetes Res Clin Pract."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1464-5491.1999.00090.x","article-title":"Effect of metformin on patients with impaired glucose tolerance","volume":"16","author":"Li","year":"1999","journal-title":"Diabetic Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2337\/diacare.25.9.1504","article-title":"Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance","volume":"25","author":"Liao","year":"2002","journal-title":"Diabetes Care."},{"key":"B35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1403494808101373","article-title":"A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems","volume":"37","author":"Lindahl","year":"2009","journal-title":"Scand J Public Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1463-1326.2010.01331.x","article-title":"Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose?","volume":"13","author":"Lindblad","year":"2010","journal-title":"Nepi Antidiabetes Study Diabetes Obesity Metabol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.2337\/diacare.26.10.2713","article-title":"Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial","volume":"26","author":"Keech","year":"2003","journal-title":"Diabetes Care."},{"key":"B38","first-page":"A687","article-title":"Preventing the development of type 2 diabetes in subjects at high risk in western Mexico, using metformin and changes in lifestyle, followed 10 years","volume":"64","author":"Polanco","year":"2015","journal-title":"Diabetes."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/archinternmed.2011.275","article-title":"Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial","volume":"171","author":"Saito","year":"2011","journal-title":"Arch Inter Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2458-11-40","article-title":"Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance","volume":"11","author":"Sakane","year":"2011","journal-title":"BMC Public Health."},{"key":"B41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1464-5491.2008.02417.x","article-title":"Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study","volume":"25","author":"Roumen","year":"2008","journal-title":"Diabetic Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results From the D-CLIP Randomized Controlled Trial","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care."},{"key":"B44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care."},{"key":"B45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1017\/S0007114512001328","article-title":"Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial","volume":"109","author":"Xu","year":"2013","journal-title":"Br J Nutr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3760\/cma.j.issn.0376-2491.2015.40.013","article-title":"Effects of lifestyle and quantitative nutrition interventions on individuals with prediabetes","volume":"95","author":"Zong","year":"2015","journal-title":"Natl Med J China."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2012.05.019","article-title":"Statins, risk of diabetes, and implications on outcomes in the general population","volume":"60","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA J Am Med Assoc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-133-1-200007040-00016","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"133","author":"Defronzo","year":"2000","journal-title":"Ann Inter Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2337\/dc12-1050","article-title":"Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes","volume":"36","author":"Tsur","year":"2013","journal-title":"Diabetes Care."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1210\/en.2017-00265","article-title":"The role of vitamin D in the prevention of type 2 diabetes. To D or not to D?","volume":"158","author":"Angellotti","year":"","journal-title":"Endocrinology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/dom.13121","article-title":"Different intervention strategies for preventing type 2 diabetes mellitus in China: a systematic review and network meta-analysis of randomized controlled trials","volume":"20","author":"Pang","year":"2018","journal-title":"Diabetes Obes Metab."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:36:46Z","timestamp":1569281806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":52,"alternative-id":["10.3389\/fendo.2019.00455"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00455","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"article-number":"455"}}